Lupin Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension".
Lupin Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension".